- UroToday Home
- Urologic Oncology
The Latest Renal Cancer Research
Recent Abstracts
-
Cancer-Associated Fibroblasts Promote Development of Papillary Renal Cell Carcinoma by Inducing Histone Lactylation of RBM15B to Modify in an m6A-Dependent Manner on ANLN.Renal CancerJune 4, 2026
-
Comparative effectiveness and cost-effectiveness of an artificial intelligence workflow for small renal mass diagnosis on computed tomography.Renal CancerJune 4, 2026
-
Survival Trends in Metastatic Renal Cell Carcinoma Across Therapeutic Eras and Histologic Subtypes.Renal CancerJune 3, 2026
-
Co-overexpression of ELOVL2 and ELOVL5 promotes clear cell renal cell carcinoma progression through LIMK1-mediated cytoskeletal reorganization.Renal CancerJune 3, 2026
-
Should Metastatic Site Inform First-Line Therapy in Clear Cell Renal Cell Carcinoma?Renal CancerJune 2, 2026
-
Percutaneous thermal ablation versus robot-assisted partial nephrectomy for localized renal cell carcinoma: a systematic review and meta-analysis stratified by tumor complexity.Renal CancerJune 2, 2026
-
Sex-Specific Adverse Events and Cardiovascular Toxicity of Cabozantinib in Renal Cell Carcinoma: A Nine-Year Pharmacovigilance Study.Renal CancerJune 1, 2026
-
Bayesian Evaluation of Treatment Effect of Avelumab Plus Axitinib for Advanced Renal Cell Carcinoma.Renal CancerJune 1, 2026
-
Natural Products in Clear Cell Renal Cell Carcinoma: Rewiring the VHL-HIF Axis, Metabolic Plasticity, and Tumor-Immune Interactions.Renal CancerMay 29, 2026
-
Joint effects and dynamic trajectories of metabolic insulin resistance and systemic inflammation in the risk of renal cell carcinoma: a UK Biobank cohort analysis.Renal CancerMay 29, 2026
Beyond the Abstracts
-
CT-Based Renal Artery Caliber Change as a Potential Imaging Marker of Treatment Response in Renal Cell Carcinoma; an Exploratory Imaging Study - Beyond the AbstractRenal CancerMay 22, 2026
-
Development of the PREDICT-Kidney Online Tool to Promote Informed Decision-Making About Kidney Cancer Follow-up Care: A Qualitative Co-Design Study - Beyond the AbstractRenal CancerMay 20, 2026
-
Ablation and Surgery Show Comparable Long-term Outcomes for T1a Renal Cell Carcinoma: A Danish Nationwide Registry Study - Beyond the AbstractRenal CancerMay 7, 2026
-
Agreement of Axial T2-MRI Versus Contrast-Enhanced CT for Solid Renal Mass Active Surveillance - Beyond the AbstractRenal CancerMay 4, 2026
-
Node Positive Resected Renal Cell Carcinoma Portends a Poor Prognosis: Results From the Canadian Kidney Cancer Collaboration - Beyond the AbstractRenal CancerApril 28, 2026
-
Pattern of Disease Recurrence and Outcomes after Progression of High-Risk Renal Cell Carcinoma (RCC) Patients Treated with Adjuvant Immunotherapy - Beyond the AbstractRenal CancerApril 13, 2026
-
Partitioned Overall Survival: Comprehensive Analysis of Survival States over 4 Years in CheckMate 9ER Comparing First-Line Nivolumab plus Cabozantinib versus Sunitinib in Advanced Renal Cell Carcinoma - Beyond the AbstractRenal CancerApril 1, 2026
-
Surgical Management of Nonmetastatic Renal Cell Carcinoma with Inferior Vena Cava Thrombus: A Systematic Review and Network Meta-analysis - Beyond the AbstractRenal CancerMarch 17, 2026
-
Diagnostic Practice and Awareness of SDH- and FH-Deficient Renal Cell Carcinoma: Results from an Italian Study Group of Uropathology (GIUP) Survey - Beyond the AbstractRenal CancerMarch 11, 2026
-
Immunotherapy Combinations in Favourable Risk Score Metastatic Renal Cell Carcinoma, an Individual Patients Data Metanalysis - Beyond the AbstractRenal CancerMarch 10, 2026